GPIA Takes Firm Stance Against Required Pediatric Studies For Generics
Executive Summary
Generic drug sponsors bear no responsibility for pediatric studies for multisource drugs, the Generic Pharmaceutical Industry Association told FDA in March 3 comments on implementation of FDAMA pediatric exclusivity provisions and the agency's pediatric rule.
You may also be interested in...
ANDA Suitability Petitions Require Pediatric Study Waiver, Merck Says
ANDA suitability petitions may be submitted only if FDA's pediatric studies requirement has been waived, Merck argued in comments on the agency's draft guidance for complying with the pediatric rule.
ANDA Suitability Petitions Require Pediatric Study Waiver, Merck Says
ANDA suitability petitions may be submitted only if FDA's pediatric studies requirement has been waived, Merck argued in comments on the agency's draft guidance for complying with the pediatric rule.
Sertraline Capsules Are Not Suitable For ANDA Due To Food Effect - Pfizer
An ANDA suitability petition for a capsule formulation of sertraline (Pfizer's Zoloft) should be denied by FDA because the capsule behaves differently from the tablet when ingested with food, Pfizer argued in a Nov. 21 letter to the agency.